Literature DB >> 17962390

Sequencing of the CHST6 gene in Czech macular corneal dystrophy patients supports the evidence of a founder mutation.

P Liskova1, B Veraitch, K Jirsova, M Filipec, A Neuwirth, N D Ebenezer, P G Hysi, A J Hardcastle, S J Tuft, S S Bhattacharya.   

Abstract

AIMS: To characterise the role of the carbohydrate sulfotransferase gene (CHST6) in macular corneal dystrophy (MCD) in Czech patients.
METHODS: The coding region of the CHST6 gene was directly sequenced in 10 affected and five unaffected members from eight apparently unrelated MCD families. The type of MCD was determined by enzyme-linked immunosorbent assay of antigenic keratan sulfate (KS) in serum and by immunohistochemical staining of corneas with monoclonal anti-KS antibody.
RESULTS: The following changes in the coding sequence of the CHST6 gene were observed; homozygous mutation of c.1A>T (p.M1?); homozygous mutation c.599T>G (p.L200R); compound heterozygosity for c.599T>G and c.614G>A (p.R205Q); compound heterozygosity for c.494G>A (p.C165Y) and c.599T>G; heterozygous c.599T>G mutation and no other change in the coding sequence. One proband exhibited no changes. The pathogenic mutation c.599T>G (p.L200R) was in allelic association with the c.484C>G (p.R162G) polymorphism. Nine patients from seven families were of MCD type I including the subtype IA.
CONCLUSION: Four different CHST6 missense mutations, of which p.C165Y is novel, were identified. Allelic association of the c.[484C>G; 599T>G] in six probands out of eight, as well as occurrence of this particular allele in a heterozygous state in one healthy control individual, supports a common founder effect for MCD in the Czech Republic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962390     DOI: 10.1136/bjo.2007.125252

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Macular corneal dystrophy and associated corneal thinning.

Authors:  L Dudakova; M Palos; M Svobodova; J Bydzovsky; L Huna; K Jirsova; A J Hardcastle; S J Tuft; P Liskova
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

Review 2.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

3.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

4.  A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Authors:  Jing Zhang; Dan Wu; Yue Li; Yidan Fan; Yiqin Dai; Jianjiang Xu
Journal:  Aging (Albany NY)       Date:  2019-02-04       Impact factor: 5.682

5.  Novel mutations of CHST6 in Iranian patients with macular corneal dystrophy.

Authors:  Shiva Akbari Birgani; Zivar Salehi; Masoud Houshmand; Mohamad Javad Mohamadi; Leila Azizade Promehr; Zahra Mozafarzadeh
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

6.  Detailed corneal and genetic characteristics of a pediatric patient with macular corneal dystrophy - case report.

Authors:  Anna Nowińska; Edyta Chlasta-Twardzik; Michał Dembski; Ewa Wróblewska-Czajka; Klaudia Ulfik-Dembska; Edward Wylęgała
Journal:  BMC Ophthalmol       Date:  2021-07-23       Impact factor: 2.209

Review 7.  Keratan sulfate, a complex glycosaminoglycan with unique functional capability.

Authors:  Bruce Caterson; James Melrose
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.